Episode 16: Behind the landmark WHO decision on essential medicines for MS

Multiple sclerosis (MS) treatments have been successfully added to the World Health Organisation’s Essential Medicines List (EML). Nick Rijke of the MS International Federation and Deanna Saylor of Johns Hopkins Hospital discuss the impact of this milestone and the next steps for clinicians, researchers, patients, and the MS community at large.